Explore the Potential with AI-Driven Innovation
The specialised, focused library is developed on demand with the most recent virtual screening and parameter assessment technology, guided by the Receptor.AI drug discovery platform. This approach exceeds the capabilities of traditional methods and offers compounds with higher activity, selectivity, and safety.
We carefully select specific compounds from a vast collection of over 60 billion molecules in virtual chemical space. Our partner Reaxense helps in synthesizing and delivering these compounds.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
We use our state-of-the-art dedicated workflow for designing focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes in-depth molecular simulations of both the catalytic and allosteric binding pockets, with ensemble virtual screening focusing on their conformational flexibility. For modulators, the process includes considering the structural shifts due to reaction intermediates to boost activity and selectivity.
Key features that set our library apart include:
partner
Reaxense
upacc
Q8N5D6
UPID:
GBGT1_HUMAN
Alternative names:
Forssman glycolipid synthase-like protein
Alternative UPACC:
Q8N5D6; A8K633; B2RA95; B7Z8S5; Q45F07; Q5T7U9; Q5T7V1; Q8N2K4; Q9UKI5
Background:
Globoside alpha-1,3-N-acetylgalactosaminyltransferase 1, also known as Forssman glycolipid synthase-like protein, plays a pivotal role in glycosphingolipid metabolism. Despite losing its ability to synthesize Forssman glycolipid antigen (FORS1/FG), this protein may have adopted an alternative function within the glycosyltransferase 6 family, evidenced by its evolutionary pressure.
Therapeutic significance:
Understanding the role of Globoside alpha-1,3-N-acetylgalactosaminyltransferase 1 could open doors to potential therapeutic strategies.